February 2006 Research News

Page last modified on: July 24, 2008
Care until the Cure

If Sentinel Lymph Node Is Positive, Then Standard Lymph Node Surgery Is Necessary?
If you've been diagnosed with breast cancer you may be unsure which type of lymph node surgery you should have. Read more…

Taxotere/Cyclophosphamide Improves Disease-Free Survival
If you have early-stage breast cancer and are considering chemotherapy, you have many options. Read more…

Radiation After DCIS Surgery Reduces Recurrence
Deciding whether or not to have radiation after DCIS surgery can be difficult. This study gives you more information. Read more…

Radiation Benefits Women With Small Cancers After Lumpectomy
This study examines whether there is a group of women with small, early-stage invasive breast cancer who can skip radiation after surgery. Read more…

Herceptin After Chemotherapy Reduces Recurrence in Women with Early-Stage, HER2-Positive Breast Cancer
If your doctor has told you that you have early-stage, HER2-positive breast cancer and will need chemotherapy after surgery, you might want to read this article. Read more…

Avastin Given With Taxol Slows Advanced Breast Cancer
If you're looking for promising new medicines that can work well with chemotherapy, you might want to read this article. Read more…

The February 2006 Research News section was made possible by an unrestricted educational grant from Genentech BioOncology.

Promotion

Comcast Pink Ribbon Campaign

An original video-on-demand educational initiative brought to you by Breastcancer.org and Comcast. Visit www.comcast.net/pinkribbon each week through the end of October for engaging, up-to-date videos and information about the fight to end breast cancer.

Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2008 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.